User:Mr. Ibrahem/Lixisenatide

Lixisenatide, sold under the brand name Lyxumia and Adlyxin, is a medication used to treat type 2 diabetes. It is used with other medications, diet, and exercise when these are not sufficient. It is given by injection under the skin.

Common side effects include nausea, diarrhea, and headache. Other side effects may include low blood sugar and allergic reactions. Use in pregnancy not recommended. It is a GLP-1 receptor agonist which increases production of insulin by the pancreas.

Lixisenatide was approved for medical use in Europe in 2013 and the United States in 2016. In the United Kingdom a month of medication costs the NHS about £58 as of 2021. In the United States this amount costs about 660 USD. A combination medication is available with insulin glargine.